61 The first-in-class peroxiredoxin 3 (PRX3) inhibitor RSO-021 modulates the mesenchymal and immune phenotype in mesotheliomaBrian Cunniff,Terri Messier, Victoria Gibson,David Seward,Essa Baitei, Peter Wells Jordan,Charlotte Poile,Joanna Dzialo,Aleksandra Bzura,Kudzayi Kutywayo,Apostolos Nakas, George Naumov,Dean FennellLung Cancer(2024)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要